Literature DB >> 14515005

A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Hiroyuki Koshiyama1, Takeshi Fujisawa, Naomitsu Kuwamura, Yoshio Nakamura, Hiroshi Kanamori, Emi Oida, Akira Hara, Takashi Suzuki, Hironobu Sasano.   

Abstract

The diagnosis of aldosterone-producing adenoma (APA) is challenging for endocrinologists, as APA does not always present with the typical constellation of clinical and laboratory features, such as hypertension, hypokalemia, suppressed plasma renin activity (PRA), and high plasma aldosterone concentration (PAC). Very recently, several studies have indicated that APA can be discovered even in normokalemic subjects with normal PRA more frequently than previously considered. Here we report a case of APA associated with chronic renal failure, which showed normokalemia and normal PRA. The patient was referred to our clinic for evaluation of an incidentally discovered adrenal mass with abnormally high PAC. After 6 yr, it was found that the right adrenal tumor showed a marked increase in size. Endocrinological examinations indicated normal PRA and markedly high PAC. Aldosterone showed a better response to the upright posture test than that to ACTH stimulation test. The diagnosis of APA was made based on the markedly high PAC to PRA ratio and the adrenocortical scintigraphy, which showed unequivocal uptake into the tumor. Right laparoscopic adrenalectomy was performed, revealing a right adrenocortical adenoma with massive hemorrhage. Histopathological examinations revealed the presence of two independent adrenocortical adenomas, one APA with predominant clear tumor cells and few c17 (17alpha-hydroxylase) immunoreactivity and the other, cortisol producing adenoma with compact cytoplasm and abundant C17 immunoreactivity. This case indicates a difficulty of diagnosis of "normoreninemic APA" with renal failure. This case is in line with the recent concept that APA is a continuous condition in which only a minority of patients have the classical clinical picture of primary aldosteronism such as hypokalemia. It is possible that normokalemic APA constitutes the most common presentation of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515005     DOI: 10.1385/ENDO:21:3:221

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  18 in total

1.  Cautions over the current epidemic of primary aldosteronism.

Authors:  N M Kaplan
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

2.  High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

Authors:  P O Lim; E Dow; G Brennan; R T Jung; T M MacDonald
Journal:  J Hum Hypertens       Date:  2000-05       Impact factor: 3.012

3.  Pathologic features of prognostic significance in adrenocortical carcinoma.

Authors:  L M Weiss; L J Medeiros; A L Vickery
Journal:  Am J Surg Pathol       Date:  1989-03       Impact factor: 6.394

4.  Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.

Authors:  K Oka; K Hayashi; T Nakazato; T Suzawa; K Fujiwara; T Saruta
Journal:  Intern Med       Date:  1997-10       Impact factor: 1.271

5.  Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.

Authors:  Y Nakamura; Y Son; Y Kohno; D Shimono; N Kuwamura; H Koshiyama; H Sasano; T Matsuda
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

6.  A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.

Authors:  R Taniguchi; H Koshiyama; M Yamauchi; S Tanaka; D Inoue; Y Sato; A Sugawa; Y Muramatsu; H Sasano
Journal:  Tohoku J Exp Med       Date:  1998-11       Impact factor: 1.848

7.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

8.  Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.

Authors:  C Letizia; S Mazzaferro; S Morabito; A De Ciocchis; S Cerci; C D'Ambrosio; G A Cinotti; D Scavo
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

9.  A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment.

Authors:  K Matsuda; K Shimamoto; N Ura; H Ogata; Y Shizukuda; M Iwakura; A Nozawa; K Kikuchi; O Iimura
Journal:  Endocrinol Jpn       Date:  1989-10

10.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11
View more
  3 in total

1.  A case of primary aldosteronism with end stage renal disease.

Authors:  Hyun Hee Na; Kyung Jun Park; Sun Young Kim; Haeng Il Koh
Journal:  Electrolyte Blood Press       Date:  2006-11

2.  Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.

Authors:  Yi-Chun Chen; Yu-Chieh Su; Chang-Kuo Wei; Jainn-Shiun Chiu; Chih-En Tseng; Shao-Jer Chen; Yuh-Feng Wang
Journal:  J Biomed Biotechnol       Date:  2011-04-07

3.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.